FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. What is described is a method for preparing a transdermal therapeutic system based on poly(lactic-co-glycolic acid) involving dissolving poly lactide-co-glycolide and a pharmaceutically active substance in an organic solvent, mixing the prepared solution until dissolved completely, hot air drying until dry completely and having a constant weight to prepare a film, cutting the film into sections and packing, with the relation of lactide and glycolide varying within the range of 95:5 to 5:95 (versions).
EFFECT: preparing the transdermal therapeutic system based on poly(lactic-co-glycolic acid) that is biodegradable.
33 cl, 1 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERMITTENT REACTOR AND ITS APPLICATION FOR POLYMERISATION OF LACTONS | 2013 |
|
RU2570904C2 |
| PEPTIDE AGENT POSSESSING ANALGESIC ANTI-INFLAMMATORY ACTION, AND BASED DOSAGE FORMS | 2012 |
|
RU2528094C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE HEPTAPEPTIDES, HAVING ANTISPASMODIC, ANXIOLYTIC, CENTRAL ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY, AS WELL AS ANTI-ALCOHOL ACTIVITY | 2012 |
|
RU2506269C1 |
| AGENT OF PEPTIDE STRUCTURE POSSESSING ANTI-INFLAMMATORY, ANTIBACTERIAL, WOUND-HEALING, REGENERATIVE, ANALGESIC, BURNTREATING ACTION AND BASED DOSAGE FORMS | 2012 |
|
RU2517213C2 |
| TRANSDERMAL SYSTEMS PREVENTING ABUSE AND MISUSE | 2015 |
|
RU2700926C2 |
| POLYESTER AND POLYESTER-BASE CONJUGATE | 1994 |
|
RU2185393C2 |
| PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ALPRAZOLAM | 2018 |
|
RU2694232C1 |
| BIODEGRADABLE THREE-BLOCK POLYESTER/POLYETHYLENE GLYCOL COPOLYMERS POSSESSING LOW MOLECULAR MASS AND REVERSIBLE THERMAL GELLING PROPERTIES | 1999 |
|
RU2232779C2 |
| IONIC CONJUGATE EXHIBITING PROLONGED PERIOD OF PEPTIDE RELEASE, METHOD OF SYNTHESIS OF IONIC CONJUGATE, METHOD OF SYNTHESIS OF MICROPARTICLES | 1994 |
|
RU2146128C1 |
| BAB TRIBLOCK POLYMERS HAVING IMPROVED RELEASE CHARACTERISTICS | 2010 |
|
RU2575844C2 |
